XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Initial Public Offering
6 Months Ended
Jun. 30, 2024
Initial Public Offering  
Initial Public Offering

Note 3 – Initial Public Offering

 

On April 5, 2022, the Company sold 11,500,000 Units (including the issuance of 1,500,000 Units as a result of the underwriter’s fully exercise of the over-allotment) at a price of $10.00 per Unit, generating gross proceeds of $115,000,000 related to the IPO. Each Unit consists of one ordinary share, one redeemable warrant (each a “Warrant”, and, collectively, the “Warrants”), and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an Initial Business Combination. Each redeemable warrant entitles the holder thereof to purchase one ordinary share, and each ten rights entitles the holder thereof to receive one ordinary share at the closing of a Business Combination. No fractional shares issued upon separation of the Units, and only whole Warrants will trade.

 

The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 Public Units to cover over-allotments. On April 5, 2022, the underwriter exercised the over-allotment option in full to purchase 1,500,000 Public Units, at a purchase price of $10.00 per Public Unit, generating gross proceeds to the Company of $15,000,000 (see Note 7).

 

On January 26, 2023, an Extraordinary General Meeting of shareholders was held to approve the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination twelve (12) times for an additional one (1) month each time from February 5, 2023 to February 5, 2024. In connection with the Extraordinary General Meeting, a total of 5,885,324 ordinary shares were presented for redemption in connection with the Extraordinary General Meeting.

 

On October 30, 2023, an Extraordinary General Meeting of shareholders was held to approve the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from February 5, 2024 to August 5, 2024. To effectuate each monthly extension, the Company and/or its Sponsor will deposit the lesser of (i) $50,000 for all remaining public shares and (ii) $0.033 for each remaining public share into the Trust Account. In connection with the Extraordinary General Meeting, a total of 2,412,260 ordinary shares were presented for redemption in connection with the Extraordinary General Meeting.

 

On August 6, 2024, the Company filed the preliminary proxy statements to SEC, which had proposed to amend the memorandum and articles of association of the Company to extend the date of consummate a business combination to April 5, 2025. For further information reference to the Note 9.

 

At June 30, 2024, the ordinary shares reflected in the balance sheet are reconciled in the following tables:

 

      
Gross proceeds from public shares  $115,000,000 
Less:     
Proceeds allocated to public rights   (8,510,000)
Proceeds allocated to public warrants   (5,290,000)
Allocation of offering costs related to ordinary shares   (5,020,172)
Redemption of Public Shares   (86,382,792)
Plus:     
Accretion of carrying value to redemption value   21,287,903 
Subsequent measurement of Class A ordinary shares subject to possible redemption (interest earned and unrealized gains on trust account)   5,549,301 
Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account)  $36,634,240